Preclinical Peptide Stability: Design Considerations for EU IND Submissions
Understanding ICH S7A, Q1A(R2), and EMA Bioanalytical Method Validation requirements for peptide stability studies supporting EU regulatory packages.
26 March 20262 min read
Research Repository
Research Blog
Technical articles for EU pharmaceutical professionals on peptide CDMO sourcing, preclinical workflows, and regulatory compliance.
Filtered by:Clear
EMA Guidelines on Synthetic Peptide Drug Substance Characterisation: 2025 Update
A comprehensive review of EMA reflection papers and guideline updates affecting identity, purity, and impurity control for synthetic peptide APIs in EU regulatory submissions.
20 March 20262 min read
